As of April 16, 2025, Mirum Pharmaceuticals (MIRM) has a market cap of $1.89 billion USD. According to our data, Mirum Pharmaceuticals is ranked No.4064 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.89 B |
-4.61%
|
Dec 31, 2024 | $1.98 B |
40.07%
|
Dec 29, 2023 | $1.42 B |
51.38%
|
Dec 30, 2022 | $0.94 B |
22.26%
|
Dec 31, 2021 | $0.77 B |
-8.65%
|
Dec 31, 2020 | $0.84 B |
-28.79%
|
Dec 31, 2019 | $1.18 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Madrigal Pharmaceuticals
MDGL
|
$7.09 B |
-0.000 M
|
![]() USA
|
![]() Genfit
GNFT
|
$0.18 B |
0.000 M
|
![]() France
|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.77 B |
-0.000 M
|
![]() USA
|
![]() Viking Therapeutics
VKTX
|
$2.59 B |
-0.000 M
|
![]() USA
|
![]() Akero Therapeutics
AKRO
|
$3.03 B |
0.000 M
|
![]() USA
|
![]() 89bio
ETNB
|
$0.88 B |
-0.000 M
|
![]() USA
|
![]() Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
![]() Israel
|
![]() Enanta Pharmaceuticals
ENTA
|
$0.11 B |
-0.000 M
|
![]() USA
|
Market Cap | = | MIRM Stock Price | * | MIRM Shares Outstanding |
= | $38.63 | * | 49.01 M | |
= | $1.89 B |